Epicore Biosystems
Series B in 2025
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
Canid is a company focused on improving the vaccination process for pediatricians through innovative technology. It has developed a scanning system that streamlines the management of vaccination records by eliminating manual data entry and automatically uploading vaccine information into state registries. Additionally, Canid provides a dashboard and process tool that offers administrative consulting, automates vaccine workflows, and manages vaccine inventory. By enhancing the efficiency of vaccination record management, Canid enables pediatric practitioners and state officials to concentrate on their core responsibilities, ultimately facilitating better healthcare outcomes for children.
Centaur Labs
Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Hopscotch Primary Care
Series C in 2024
Hopscotch Primary Care is a data-driven healthcare startup that aims to transform healthcare in rural communities by delivering tailored, high-quality care through a team-based model. It provides resources and support for patients both inside and outside clinics, enabling healthcare professionals to deliver the care and support patients need and improving access and quality of services.
Shape specializes in developing a 3D body scanning system that allows users to digitally measure and visualize their body composition in photorealistic detail. Utilizing advanced technologies such as artificial intelligence and computer vision, Shape provides accurate assessments of body metrics that traditional methods cannot capture, including regional volume and changes in body composition. The system offers personalized insights and guidance based on individual user data, helping users track fat loss and muscle gains in an engaging manner. By delivering fast and gamified feedback, Shape aims to transform how individuals approach their health and fitness goals, enhancing motivation and progress tracking.
ParcelBio
Seed Round in 2024
ParcelBio is a biotechnology company specializing in the development of a novel, programmable method for safely and precisely delivering messenger RNA (mRNA) to diverse cell types within the body. Their technology aims to create targeted, potent, and durable RNA therapeutics, with the potential to treat a wide range of diseases, including cancer, genetic disorders, and infectious diseases.
Century Health
Pre Seed Round in 2024
Century Health is a healthcare technology company that enhances drug development and commercialization by utilizing artificial intelligence to harness otherwise inaccessible longitudinal clinical data. Its innovative platform connects with real-world, disease-specific datasets and employs AI to clean and standardize this information. This process eliminates data silos, allowing researchers to analyze real-world data more effectively and efficiently. By streamlining access to critical insights, Century Health aims to accelerate the pace of drug commercialization while upholding patient privacy and supporting the broader research community.
Oula Health
Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night.
It was founded in 2018 and is based in Chicago, Illinois.
Alvee offers an AI-driven tool for healthcare providers and payers. It assesses patients' health equity status by considering social determinants of health, chronic conditions, demographics, and health inequity risks. This enables better patient care and helps meet data stratification quality reporting requirements.
Epicore Biosystems
Venture Round in 2024
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Emm is a company focused on consumer health technology, developing tools to help individuals manage their health on their terms. It is building a menstrual cup with integrated biosensors designed to track biometric data and deliver personalized insights about menstrual health. The device aims to redefine period experiences by providing actionable information that helps users understand their health through technology and expert knowledge.
Ellipsis Health
Series A in 2023
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Canid is a company focused on improving the vaccination process for pediatricians through innovative technology. It has developed a scanning system that streamlines the management of vaccination records by eliminating manual data entry and automatically uploading vaccine information into state registries. Additionally, Canid provides a dashboard and process tool that offers administrative consulting, automates vaccine workflows, and manages vaccine inventory. By enhancing the efficiency of vaccination record management, Canid enables pediatric practitioners and state officials to concentrate on their core responsibilities, ultimately facilitating better healthcare outcomes for children.
Ossium Health
Series C in 2023
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
3X Genetics
Pre Seed Round in 2023
3X Genetics is a company focused on developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company has created innovative technologies that allow for proactive screening of the population for conditions such as myotonic dystrophy and other trinucleotide repeat issues associated with progressive muscle weakness. By enabling healthcare professionals to detect these genetic disorders early, 3X Genetics plays a crucial role in preventing the birth of children affected by serious genetic diseases.
MedScout
Seed Round in 2023
MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.
Train Fitness
Seed Round in 2023
Train Fitness specializes in a workout tracking platform that utilizes artificial intelligence to automatically detect exercise sets and repetitions during strength training. By analyzing motion data from the Apple Watch, Train provides users with expertise-level insights into their workouts. This technology enables real-time coaching, allowing fitness enthusiasts to identify weaknesses, monitor their progress, and enhance their performance. The company's focus on automatic exercise detection positions it as a valuable resource for individuals looking to improve their fitness regimen.
MEND is a life sciences company dedicated to improving health outcomes through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that aid in healing from injuries, surgeries, and illness, as well as enhancing physical performance and addressing the challenges of aging. MEND's innovations have gained acceptance in various sectors, including hospitals, health systems, professional sports teams across major leagues, and elite military forces in the United States. The company's commitment to ongoing research and development positions it as a key player in the field of clinical nutritional products, aimed at enabling caregivers to support patients in achieving optimal health and recovery.
Pathfinder Health
Seed Round in 2023
Pathfinder Health is a company that focuses on supporting the development of children aged 0-5 through an evidence-based clinical tool. This tool aids in monitoring child development milestones and offers guidance on how caregivers can effectively engage with children at various stages of their growth. By facilitating communication with healthcare professionals, the app promotes earlier diagnoses of developmental concerns. It also provides users with access to a wealth of resources, including evidence-based activities, articles, parenting tips, and local early intervention services. Through its innovative approach, Pathfinder Health empowers parents and caregivers to track their child's progress and identify potential developmental issues promptly.
Rensair is a developer of portable hospital-grade air purifiers designed to enhance indoor air quality in a variety of settings, including hospitals, schools, and care homes. The company employs advanced air purification technology that utilizes high-efficiency particulate air (HEPA13) filters combined with ozone-free ultraviolet light to effectively eliminate airborne viruses, including the coronavirus. Originally created for Scandinavian hospitals, Rensair's products are now trusted by businesses worldwide, providing a reliable solution for ensuring clean air in diverse environments.
Oula Health
Series A in 2023
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Koala Health
Series A in 2022
Founded in 2021, Koala Health simplifies pet care by providing medications and health products through its digital platform. It offers features such as prescription management, date-and-time-based packaging, and free delivery.
PathSpot Technologies, Inc., established in 2017 and headquartered in New York City, specializes in food safety solutions. The company develops and manufactures a unique system that uses a proprietary algorithm to analyze fluorescent light, enabling it to scan employees' hands and detect pathogens that cause food-borne illnesses. This technology helps restaurants and their customers mitigate the risk of food-borne illnesses by providing instant, invisible signs of harmful bacteria and viruses.
Nanopath is a molecular diagnostics company that develops innovative platforms for rapid disease diagnosis. Its technology enables point-of-care testing, eliminating the need for nucleic acid amplification and supporting multiplexed detection. This allows patients and healthcare providers to access accurate diagnostic results within standard office visits, improving healthcare outcomes.
Health Note
Series A in 2022
Health Note is an AI-powered health data management platform that collects patient information through voice and digital intake tools, automatically formats it into clinical notes, and integrates with electronic medical records to streamline documentation and pre-visit workflows. The platform is frictionless and platform-agnostic, enabling patients to participate in their care without apps or portals and reducing administrative burden for clinicians while improving care team efficiency. Founded in 2018 and based in San Francisco, Health Note aims to simplify clinical documentation and EMR integration.
Swing Therapeutics
Series A in 2022
Swing Therapeutics is focused on developing innovative digital therapeutics aimed at improving the lives of individuals with chronic conditions. The company assembles a team of scientists, clinicians, and technologists who collaborate with leading researchers to create evidence-based treatments. These digital solutions are designed to empower patients, allowing them to manage their health more effectively and regain control over their illnesses. By providing transformative therapeutic options, Swing Therapeutics seeks to enhance the overall well-being of patients, enabling them to lead healthier and more fulfilling lives.
Boulder Care
Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.
Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.
NeuraLight
Series A in 2022
NeuraLight is a venture-backed company dedicated to improving the lives of billions affected by neurological disorders. It develops a digital neurology platform that uses smartphone or webcam technology to accurately assess and monitor patients, enabling better evaluation and care.
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.
Rensair is a developer of portable hospital-grade air purifiers designed to enhance indoor air quality in a variety of settings, including hospitals, schools, and care homes. The company employs advanced air purification technology that utilizes high-efficiency particulate air (HEPA13) filters combined with ozone-free ultraviolet light to effectively eliminate airborne viruses, including the coronavirus. Originally created for Scandinavian hospitals, Rensair's products are now trusted by businesses worldwide, providing a reliable solution for ensuring clean air in diverse environments.
Health Hero
Seed Round in 2022
Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Curbside Health
Seed Round in 2022
Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.
Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.
Insiteflow
Seed Round in 2021
Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.
Gordy Health
Convertible Note in 2021
Gordy Health is a virtual care provider based in Pasadena, California, founded in 2021. The company specializes in blood pressure management to reduce patients' risk of heart attack, stroke, and kidney failure. Gordy Health offers a healthcare platform that allows users to manage their blood pressure from home, with features including direct access to heart specialists, easy-to-schedule virtual appointments, real-time diagnostics, prescription delivery, and ongoing monitoring and medication adjustments. The goal is to prevent complications from high blood pressure, helping patients achieve healthier lives and increased longevity.
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.
GritWell
Seed Round in 2021
GritWell Ltd is a digital health platform that specializes in addressing chronic health conditions through a holistic approach. Founded in 2018 and based in San Francisco, the company connects patients with a variety of health professionals, including nutritionists, health coaches, and naturopathic doctors. GritWell's platform facilitates secure video consultations, direct messaging, and online scheduling, allowing for personalized treatment plans and credible advice tailored to individual needs. By focusing on root cause treatment rather than mere symptom management, GritWell employs clinically validated symptom assessments to guide patients toward appropriate care while integrating natural treatment options. This innovative approach aims to improve health outcomes by enabling patients to find practitioners who can address the underlying issues of their chronic symptoms, such as insomnia, migraines, and anxiety.
Kenshō Health
Seed Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.
Founded in 2019, Moons specializes in orthodontic solutions, offering transparent dental aligners tailored to each patient's needs. The company provides direct-to-consumer products and online dental services in Mexico and Colombia.
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Zone7
Convertible Note in 2021
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
Insiteflow
Seed Round in 2021
Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.
Scipher Medicine
Series C in 2021
Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.
Kenshō Health
Venture Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.
FULLFILL
Seed Round in 2021
FULLFILL is a digital platform offering virtual health coaching programs designed to prevent and treat chronic conditions. It partners with employers worldwide to improve employee health and reduce medical expenses. The platform offers evidence-based content, daily support from Master Coaches, and engages employees effectively, doubling medical results compared to traditional programs.
Conversa Health
Series B in 2021
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Ellipsis Health
Seed Round in 2021
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
SHINE
Venture Round in 2020
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Brio Systems
Seed Round in 2020
Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.
Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.
Conversa Health
Venture Round in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Conversa Health
Series B in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Better Life Partners
Series A in 2020
Better Life Partners Inc. is a healthcare company based in Hanover, New Hampshire, dedicated to providing comprehensive support for individuals struggling with opioid use disorder in the United States. Established in 2018, the company offers a range of services, including medication-assisted treatment, counseling, peer coaching, and group sessions. Better Life Partners focuses on delivering personalized healthcare to vulnerable populations, utilizing technology to create customizable care plans that ensure effective and reliable service delivery. By integrating medical and behavioral healthcare, the company addresses the needs of those affected by addiction, facilitating their recovery through a combination of telehealth, community-based support, and innovative care approaches. With additional offices across New Hampshire, Better Life Partners aims to make a meaningful impact on the lives of individuals seeking to overcome substance abuse challenges.
Brio Systems
Venture Round in 2020
Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Founded in 2019, Moons specializes in orthodontic solutions, offering transparent dental aligners tailored to each patient's needs. The company provides direct-to-consumer products and online dental services in Mexico and Colombia.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.
Olaris
Venture Round in 2019
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.
Kenshō Health
Pre Seed Round in 2019
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018, that focuses on developing rapid diagnostic tests for epidemic fever viruses. The company designs paper-based diagnostic systems and kits that facilitate the detection of viruses such as dengue, chikungunya, and Zika. E25Bio's innovative platform enables multiplexed testing that quickly identifies viral antigens during infections, allowing for real-time data reporting through a mobile application. This capability supports epidemiologic predictions and disease mapping, empowering governments and health organizations to respond effectively to outbreaks and manage public health crises. Through its commitment to fast, mobile testing solutions, E25Bio aims to prevent severe health outcomes associated with viral epidemics.
Brave Care
Seed Round in 2019
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.
Mahmee is an integrated care delivery platform focused on maternal and infant health. It aims to bridge critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By providing a digital infrastructure, Mahmee connects patients, independent health professionals, and large healthcare organizations to enhance access to comprehensive prenatal and postpartum care. The platform features a care management system that links health records for mothers and their babies, identifying clinical risks and facilitating collaboration among maternity and infant care practitioners. This enables healthcare providers to share care plans effectively, ensuring coordinated care. Additionally, Mahmee's marketplace allows new and expecting parents to discover community-based perinatal health providers and access care quickly, both in-person and virtually.
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.
AdaptX
Venture Round in 2019
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.
Scipher Medicine
Series B in 2019
Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.
Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.
Allevi
Venture Round in 2019
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.
Mitra Biotech
Series C in 2018
Mitra Biotech, established in 2010, is a biotechnology company based in Woburn, Massachusetts, with a laboratory office in Bengaluru, India. It specializes in personalized cancer treatment, offering a novel functional assay called CANScript. This assay replicates a patient's tumor microenvironment, measures multiple parameters, and converts them into a single score predicting clinical response to selected therapies. Mitra Biotech's technology aids biopharma companies in drug discovery and development, expanding access to personalized medicine and enhancing cancer treatment selection.
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
Apprentice Health
Seed Round in 2018
Apprentice Health optimizes clinical workflows using real-time location systems, ambient sensors, and AI. Its platform enhances patient scheduling, room utilization, and equipment tracking, reducing wait times and improving operational efficiency for healthcare providers.
Higia Technologies, founded in 2016 and based in Mexico City, specializes in developing EVA, a non-invasive wearable device aimed at assessing breast cancer risk. This innovative device features tactile sensors that map the surface of the breast and its surrounding areas. By continuously monitoring changes in breast temperature, size, and weight through embedded biosensors, EVA empowers women to actively track their breast health. The company's focus is on making breast cancer risk assessment more accessible and user-friendly.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
Lumiata is a predictive health analytics company that applies artificial intelligence to healthcare data to deliver real-time, patient-level predictions. It builds a medical graph to organize symptoms, diagnoses, procedures and medications, enabling risk-bearing organizations such as payers, hospital networks, and population health programs to forecast health trajectories, cost, and care needs. The Lumiata Risk Matrix provides time-based predictions with explanations of medical reasoning. The platform combines big data, clinical knowledge, and proprietary intellectual property drawn from over 120 million patient records to support use cases like underwriting and care management. Founded in 2013 and based in San Mateo, California, Lumiata serves providers, payers, and digital health companies, enabling predictive analytics at scale while protecting privacy.
Bainbridge Health
Seed Round in 2018
Bainbridge Health, Inc. is a Philadelphia-based company founded in 2016 that specializes in developing a clinical intelligence and data analytics platform aimed at enhancing medication safety in hospital settings. The company's offerings include a vendor-agnostic medication safety platform that streamlines data management, reducing the reliance on manual data clerking and ad-hoc reporting. Their solutions, designed for medication safety leaders and hospital safety professionals, include an infusion pump management software known as InfusionWare, which centralizes infusion data to improve patient safety and effectively manage pump information. By mitigating medication errors, Bainbridge Health's platform helps healthcare providers reduce avoidable costs and improve overall patient care.
SonderMind
Venture Round in 2018
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.
RubiconMD
Series B in 2018
RubiconMD, Inc. is a healthcare technology company that offers an online platform facilitating communication between primary care clinicians and specialists through eConsults. Founded in 2013 and headquartered in New York, RubiconMD enables primary care providers to quickly seek guidance and opinions on medical cases, thereby enhancing patient care and reducing costs. The platform allows clinicians to identify specialists based on various criteria, such as ratings and experience, ensuring informed decision-making in patient management. Additionally, RubiconMD provides continuing medical education (CME) programs, including live and on-demand webinars, and features RubiconRx, a clinical pharmacy service that supports medication management for patients. The company serves a diverse clientele, including employers, community health centers, health plans, and direct primary care practices, and also offers services related to electronic health records, workflow integration, and clinician engagement.
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
DOTS
Venture Round in 2018
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
Innoblative Designs
Venture Round in 2018
Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Established in 2013, the company specializes in the development of innovative electrosurgical devices aimed at enhancing surgical procedures. One of its key products is Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device. This device utilizes bipolar current to create a controlled zone of ablation during surgery, facilitating the coagulation and ablation of soft tissue beds. Sira's unique design features a saline microinfusion system that ensures optimal contact with target tissue, allowing it to be seamlessly integrated with existing electrosurgical generators in operating rooms. This makes Sira an accessible and effective option for surgeons seeking to improve intraoperative ablation techniques.
RubiconMD
Series B in 2018
RubiconMD, Inc. is a healthcare technology company that offers an online platform facilitating communication between primary care clinicians and specialists through eConsults. Founded in 2013 and headquartered in New York, RubiconMD enables primary care providers to quickly seek guidance and opinions on medical cases, thereby enhancing patient care and reducing costs. The platform allows clinicians to identify specialists based on various criteria, such as ratings and experience, ensuring informed decision-making in patient management. Additionally, RubiconMD provides continuing medical education (CME) programs, including live and on-demand webinars, and features RubiconRx, a clinical pharmacy service that supports medication management for patients. The company serves a diverse clientele, including employers, community health centers, health plans, and direct primary care practices, and also offers services related to electronic health records, workflow integration, and clinician engagement.
ActiveProtective
Series A in 2018
ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ from what is allowable.
This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection.
ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania.
Lumiata is a predictive health analytics company that applies artificial intelligence to healthcare data to deliver real-time, patient-level predictions. It builds a medical graph to organize symptoms, diagnoses, procedures and medications, enabling risk-bearing organizations such as payers, hospital networks, and population health programs to forecast health trajectories, cost, and care needs. The Lumiata Risk Matrix provides time-based predictions with explanations of medical reasoning. The platform combines big data, clinical knowledge, and proprietary intellectual property drawn from over 120 million patient records to support use cases like underwriting and care management. Founded in 2013 and based in San Mateo, California, Lumiata serves providers, payers, and digital health companies, enabling predictive analytics at scale while protecting privacy.
Celularity
Venture Round in 2017
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies targeting various diseases, including cancer, infectious, and degenerative conditions.
Iris Plans
Seed Round in 2017
Iris Plans, Inc. is a technology-driven company that offers advance care planning (ACP) services tailored for individuals facing serious medical conditions. Founded in 2015 and based in Austin, Texas, the company utilizes a telehealth platform to connect healthcare professionals with patients and their families, facilitating the creation of personalized healthcare plans to guide critical medical decisions. Iris Plans provides a range of services, including the completion of living will documents, medical power of attorney arrangements, and directives to physicians, all customized to meet the legal requirements of each state. The company emphasizes the importance of ACP by highlighting its benefits, which include improved quality of care, reduced stress for families, increased satisfaction, and lower healthcare costs. Iris Plans serves customers across the United States, striving to alleviate the burdens associated with serious medical conditions through comprehensive and accessible planning solutions.
Innoblative Designs
Venture Round in 2017
Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Established in 2013, the company specializes in the development of innovative electrosurgical devices aimed at enhancing surgical procedures. One of its key products is Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device. This device utilizes bipolar current to create a controlled zone of ablation during surgery, facilitating the coagulation and ablation of soft tissue beds. Sira's unique design features a saline microinfusion system that ensures optimal contact with target tissue, allowing it to be seamlessly integrated with existing electrosurgical generators in operating rooms. This makes Sira an accessible and effective option for surgeons seeking to improve intraoperative ablation techniques.
Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.
Iris Plans
Seed Round in 2016
Iris Plans, Inc. is a technology-driven company that offers advance care planning (ACP) services tailored for individuals facing serious medical conditions. Founded in 2015 and based in Austin, Texas, the company utilizes a telehealth platform to connect healthcare professionals with patients and their families, facilitating the creation of personalized healthcare plans to guide critical medical decisions. Iris Plans provides a range of services, including the completion of living will documents, medical power of attorney arrangements, and directives to physicians, all customized to meet the legal requirements of each state. The company emphasizes the importance of ACP by highlighting its benefits, which include improved quality of care, reduced stress for families, increased satisfaction, and lower healthcare costs. Iris Plans serves customers across the United States, striving to alleviate the burdens associated with serious medical conditions through comprehensive and accessible planning solutions.